Precision BioSciences to Present at Upcoming Sidoti Conference
November 10 2023 - 7:00AM
Business Wire
Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene
editing company utilizing its novel proprietary ARCUS® platform to
develop in vivo gene editing therapies for sophisticated gene
edits, including gene insertion, excision, and elimination, today
announced that the Company will present at the Sidoti November
Micro Cap Conference taking place November 15-16, 2023.
Details for the presentation are as follows:
Date: November 15, 2023 Time: 10:45 AM ET
The presentation will be available on Precision’s website under
the Investors section under Events & Presentations on November
15, 2023 at investor.precisionbiosciences.com. An archived replay
will be available for approximately 30 days following the
event.
About Precision BioSciences, Inc. Precision BioSciences,
Inc. is an advanced gene editing company dedicated to improving
life (DTIL) with its novel and proprietary ARCUS® genome editing
platform that differs from other technologies in the way it cuts,
its smaller size, and its simpler structure. Key capabilities and
differentiating characteristics may enable ARCUS nucleases to drive
more intended, defined therapeutic outcomes. Using ARCUS, the
Company’s pipeline is comprised of in vivo gene editing candidates
designed to deliver lasting cures for the broadest range of genetic
and infectious diseases where no adequate treatments exist. For
more information about Precision BioSciences, please visit
www.precisionbiosciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231110053639/en/
Investor and Media Contact: Mei Burris Senior Director of
Finance and Corporate Controller
Mei.Burris@precisionbiosciences.com
Precision BioSciences (NASDAQ:DTIL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Precision BioSciences (NASDAQ:DTIL)
Historical Stock Chart
From Apr 2023 to Apr 2024